Answers are grounded in this paper and cite their sources.
This survey highlights the burden of CD symptoms, even in patients undergoing regular treatment. Symptom re-emergence is common and has significant impact on daily activities and quality of life. Greater awareness of the therapeutic profile of BoNT-A treatment should lead to better informed therapeutic discussions and planning.
No takes yet. Share an insight, caveat, or question.
Comella et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: